IM 0.5 mL (1 dose).
Adult ≥18 yr & those previously vaccinated w/ pneumococcal polysaccharide vaccine 1 single dose.
Childn 2-17 yr 1 single dose,
12-23 mth 2 doses w/ at least 2 mth interval between doses.
Unvaccinated childn 2-17 yr 1 single dose of 0.5 mL,
12-23 mth 2 doses of 0.5 mL w/ at least 2 mth interval between doses,
infant 7-11 mth 2 doses of 0.5 mL w/ at least 1 mth interval, followed by 3rd dose at 2 yr.
Infant 6 wk-6 mth 3-dose primary series: 1st dose given at 2 mth of age w/ at least 1 mth interval between doses, may be given as early as 6 wk of age. 4th dose (booster) given between 11 & 15 mth of age. 2-dose primary series: Routine infant immunization program: 1st dose given at 2 mth of age & the 2nd dose is 2 mth later. 3rd dose (booster) given between 11 & 15 mth of age.
Preterm infant (<37 wk gestation) 1st dose given at 2 mth of age & w/ at least 1 mth interval between doses, may be given as early as 6 wk of age. 4th dose (booster) is recommended at approx 12 mth of age.
Patients at higher risk of pneumococcal infection & previously vaccinated w/ 23-valent pneumococcal polysaccharide vaccine (PPSV23) 2 doses w/ 6 mth interval between doses.
Naive individuals 2 doses w/ 1 mth interval between doses.
Individuals w/ hematopoietic stem cell transplant (HSCT) 3-dose primary series: 1st dose given 3-6 mth after HSCT & w/ 1 mth interval between doses. Booster dose is recommended 6 mth after the 3rd dose.